Company news

Ceretas Ltd news in 2026

Ceretas Ltd's news releases, calls and decks from 2026, newest first.

View company

Quarterly Activities/Appendix 4C Cash Flow Report

October 29, 2026

Quarterly Activities/Appendix 4C Cash Flow Report

October 29, 2026

First Patient Enrolled in Phase 2 CERE-CALM Clinical Trial

October 28, 2026

First Patient Enrolled in Phase 2 CERE-CALM Clinical Trial

October 28, 2026

Notice of Annual General Meeting/Proxy Form

October 21, 2026

Investor Presentation - October 2026

October 18, 2026

Date of AGM and Closing Date for Director Nominations

September 22, 2026

Milestone 3 Completed for CUREator Program

September 15, 2026

Ethics Committee Approval Secured for Additional Trial Sites

August 30, 2026

Appendix 4G

August 30, 2026

Corporate Governance Statement

August 30, 2026

Appendix 4E & Annual Report 30 June 2026

August 30, 2026

Change of Address

August 14, 2026

Investor Presentation

August 12, 2026

Decks in 2026